BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 18, 2011
View Archived Issues
Scientists at Novartis and IRM present novel B-raf inhibitors
Read More
Preclinical antitumor activity reported for (R)-bicalutamide derivatives ISIR-9 and ISIR-11
Read More
Amplified DNA sequences and retrotransposon elements identified in tumor-released microvesicles
Read More
Antisense oligonucleotide ASO 10-27 alleviates symptoms of severe muscular atrophy in vivo
Read More
RAGE antagonist CKH-66 reduces brain beta-amyloid in vivo
Read More
Oncolytic herpes simplex virus safe and feasible in patients with advanced pancreatic cancer
Read More
Modified aminoglycosides designed for nonsense suppression therapy in genetic diseases
Read More
Modulators of cell cycle checkpoints patented by Merck & Co.
Read More
U.S. researchers synthesize novel 15-LOX inhibitors
Read More
Lundbeck updates recent pipeline progress
Read More
New DPP IV inhibitors reported by Merck & Co.
Read More
Scientists at Takeda present new mTOR inhibitors for cancer and other disorders
Read More
Novel beta-secretase inhibitors patented jointly by Roche and Siena Biotech
Read More
Adocia's phase I HinsBet study shows encouraging results in diabetes
Read More
CytRx begins phase Ib INNO-206 study in advanced solid tumors
Read More
Fibrocell Science provides FDA final data from azficel-T histology study
Read More
ExonHit's AclarusDx receives CE marking for diagnosis of Alzheimer's
Read More
Senesco's study of SNS01-T in multiple myeloma on hold by FDA
Read More
Ariad and Merck & Co. to copromote ridaforolimus for sarcoma in U.S.
Read More
NicOx grants Ferrer option for osteoarthritis candidate naproxcinod
Read More
TaiMed Biologics and Ambrilia sign worldwide agreement for HIV programs
Read More
Anacor and Medicines for Malaria Venture agree to jointly develop AN-3661
Read More
Antisense Therapeutics continues seeking partner for ATL-1101 in prostate cancer
Read More
Phase II study with Stem Cell Therapeutics' prolactin starts in multiple sclerosis
Read More
Phase I trial of AZD-8055 in subjects with recurrent gliomas to begin this month
Read More
Anacor's phase IIb trial of AN-2728 in psoriasis reaches full enrollment
Read More
Kythera reports additional efficacy data from phase II trial of ATX-101 in submental fat
Read More